1,634
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Autoimmune inner ear disease in a young patient – an unsolvable challenge?

ORCID Icon, , &
Pages 29-34 | Received 18 Mar 2022, Accepted 30 Jan 2023, Published online: 16 Feb 2023

References

  • Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161(1_suppl):S1–S45.
  • Vambutas A, Pathak S. AAO: autoimmune and autoinflammatory (disease) in otology: what is new in immune-mediated hearing loss. Laryngoscope Investig Otolaryngol. 2016;1(5):110–115.
  • Broughton SS, Meyerhoff WE, Cohen SB. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum. 2004;34(2):544–548.
  • Vambutas A, DeVoti J, Goldofsky E, et al. Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLOS One. 2009;4(4):e5293.
  • Pathak S, Goldofsky E, Vivas EX, et al. IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol. 2011;186(3):1870–1879.
  • Vambutas A, Lesser M, Mullooly V, et al. Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease. J Clin Invest. 2014;124(9):4115–4122.
  • Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013;25(6):469–484.
  • Sakano H, Harris JP. Emerging options in immune-mediated hearing loss. Laryngoscope Investig Otolaryngol. 2019;4(1):102–108.
  • Fleischmann RM, Tesser J, Schiff MH, et al. Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65(8):1006–1012.
  • Matsuoka AJ, Harris JP. Autoimmune inner ear disease: a retrospective review of forty-seven patients. Audiol Neurootol. 2013;18(4):228–239.
  • Pathak S, Stern C, Vambutas A. N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients. Immunol Res. 2015;63(1-3):236–245.
  • Angeli SI, Abi-Hachem RN, Vivero RJ, et al. L-N-Acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss. Acta Otolaryngol. 2012;132(4):369–376.
  • Svrakic M, Pathak S, Goldofsky E, et al. Diagnostic and prognostic utility of measuring tumor necrosis factor in the peripheral circulation of patients with immune-mediated sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2012;138(11):1052–1058.
  • Van Rompaey V, De Belder F, Parizel P, et al. Semicircular canal fibrosis as a biomarker for lateral semicircular canal function loss. Front Neurol. 2016;7:43.
  • Breslin NK, Varadarajan VV, Sobel ES, et al. Autoimmune inner ear disease: a systematic review of management. Laryngoscope Investig Otolaryngol. 2020;5(6):1217–1226.